Balance Sheet

Assets

-22%

-18%

10Y

Currency: USD

	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024	Dec-2025
Assets
Cash & Cash Equivalents	28	65	196	297	224	162	205	650	907	574	463	332	413	458	456	384	432	661	662	471	434	404	488	530
Cash Equivalents	28	65	196	297	224	162	205	650	907	574	463	332	413	458	456	384	432	661	662	471	434	404	488	530
Short-Term Investments	0	83	166	116	264	62	39	95	119	239	458	277	284	329	383	371	413	454	329	399	1 356	1 203	1 176	1 011
Total Receivables	209	234	261	247	293	358	340	346	388	399	399	423	378	391	372	465	392	393	419	424	495	489	453	461
Accounts Receivables	209	234	261	247	293	358	340	346	388	399	399	423	378	391	372	465	392	393	419	424	495	489	453	461
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Inventory	166	190	206	212	253	321	376	351	398	434	455	516	471	490	525	595	584	554	622	572	719	781	760	741
Other Current Assets	63	82	80	135	96	126	135	121	164	153	161	210	170	109	108	162	202	119	107	125	153	172	153	164
Total Current Assets	467	655	908	1 008	1 130	1 029	1 094	1 563	1 975	1 798	1 937	1 757	1 716	1 778	1 845	1 977	2 023	2 180	2 140	1 990	3 158	3 048	3 030	2 906
PP&E Net	142	179	202	180	190	272	301	302	334	350	417	414	429	438	489	493	509	701	694	716	680	724	689	710
PP&E Gross	142	179	202	180	190	272	301	302	334	350	417	414	429	438	489	493	509	701	694	716	680	724	689	710
Accumulated Depreciation	187	210	248	272	300	343	375	426	479	532	595	645	660	679	739	812	818	883	961	1 002	1 009	1 067	1 109	1 261
Intangible Assets	0	12	59	28	45	210	229	205	204	259	261	266	254	214	162	174	133	146	199	254	332	321	294	174
Goodwill	70	70	113	113	119	328	322	328	364	469	495	518	500	496	477	506	220	264	292	347	406	414	411	580
Long-Term Investments	0	0	0	0	0	0	0	0	0	0	294	378	389	720	831	1 028	2 656	4 638	9 561	14 387	8 831	7 698	4 839	6 104
Other Long-Term Assets	42	76	89	96	113	132	92	138	186	221	40	55	52	65	48	95	70	80	87	104	95	95	102	103
Other Assets	70	70	113	113	119	328	322	328	364	469	495	518	500	496	477	506	220	264	292	347	406	414	411	580
Total Assets	721 N/A	993 +38%	1 372 +38%	1 427 +4%	1 596 +12%	1 972 +24%	2 037 +3%	2 536 +24%	3 063 +21%	3 097 +1%	3 444 +11%	3 389 -2%	3 341 -1%	3 710 +11%	3 851 +4%	4 273 +11%	5 611 +31%	8 009 +43%	12 973 +62%	17 799 +37%	13 502 -24%	12 299 -9%	9 364 -24%	10 577 +13%
Liabilities
Accounts Payable	50	54	71	73	83	96	118	93	113	129	131	149	129	122	133	135	122	107	139	142	135	429	369	129
Accrued Liabilities	63	106	168	171	133	171	150	173	155	138	166	161	153	158	163	172	144	215	259	313	231	180	166	208
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	7	10	9	3	3	16	10	5	233	1	2	2	0	0	0	0	0	426	2	0	0	0	1	1
Other Current Liabilities	88	69	66	72	100	131	140	148	165	191	174	177	164	161	175	195	184	157	231	225	202	197	178	178
Total Current Liabilities	209	239	315	319	320	414	418	420	667	459	472	487	447	441	471	503	451	905	632	681	569	523	468	517
Long-Term Debt	106	226	426	426	426	442	446	738	731	732	732	436	436	434	434	435	439	14	12	11	1 198	1 199	1 200	1 202
Deferred Income Tax	10	15	4	2	8	51	43	43	60	86	115	162	155	233	223	222	553	998	2 077	3 065	1 770	1 475	818	1 059
Minority Interest	0	0	0	0	0	34	30	19	4	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	13	17	29	21	24	58	60	56	65	76	108	117	119	111	135	183	148	337	372	358	350	361	309	345
Total Liabilities	338 N/A	497 +47%	775 +56%	769 -1%	777 +1%	1 000 +29%	996 0%	1 276 +28%	1 526 +20%	1 353 -11%	1 428 +6%	1 202 -16%	1 156 -4%	1 219 +5%	1 264 +4%	1 343 +6%	1 591 +18%	2 254 +42%	3 093 +37%	4 114 +33%	3 886 -6%	3 558 -8%	2 795 -21%	3 123 +12%
Equity
Common Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Earnings	345	421	489	571	674	762	852	996	1 182	1 360	1 528	1 606	1 695	1 808	1 836	1 830	3 722	5 471	9 268	13 525	9 898	9 261	7 416	8 176
Additional Paid In Capital	36	42	50	60	78	99	124	130	157	185	212	240	271	300	333	361	394	410	429	442	447	449	463	476
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	369	435	684	3	7	10	6	10	1	4	12
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	49	38	100	106	264	633	772	1 010
Other Equity	2	33	58	27	67	111	65	133	198	199	275	341	219	13	17	55	50	95	273	181	457	337	542	201
Total Equity	383 N/A	496 +30%	597 +20%	658 +10%	820 +25%	972 +19%	1 041 +7%	1 260 +21%	1 537 +22%	1 744 +13%	2 015 +16%	2 187 +9%	2 185 0%	2 491 +14%	2 587 +4%	2 930 +13%	4 020 +37%	5 755 +43%	9 880 +72%	13 685 +39%	9 615 -30%	8 741 -9%	6 569 -25%	7 454 +13%
Total Liabilities & Equity	721 N/A	993 +38%	1 372 +38%	1 427 +4%	1 596 +12%	1 972 +24%	2 037 +3%	2 536 +24%	3 063 +21%	3 097 +1%	3 444 +11%	3 389 -2%	3 341 -1%	3 710 +11%	3 851 +4%	4 273 +11%	5 611 +31%	8 009 +43%	12 973 +62%	17 799 +37%	13 502 -24%	12 299 -9%	9 364 -24%	10 577 +13%
Shares Outstanding
Common Shares Outstanding	25	26	26	26	27	27	27	28	28	28	28	29	29	29	30	30	30	30	30	30	30	29	28	27

Income Statement Balance Sheet Cash Flow Statement

Bio Rad Laboratories Inc
NYSE:BIO

Balance Sheet

Balance Sheet Decomposition
Bio Rad Laboratories Inc

Balance Sheet
Bio Rad Laboratories Inc

See Also

Company

Help

Tools

Stocks

Bio Rad Laboratories Inc NYSE:BIO

Balance Sheet

Balance Sheet Decomposition Bio Rad Laboratories Inc

Balance Sheet Bio Rad Laboratories Inc

See Also

Company

Help

Tools

Stocks

Bio Rad Laboratories Inc
NYSE:BIO

Balance Sheet Decomposition
Bio Rad Laboratories Inc

Balance Sheet
Bio Rad Laboratories Inc